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The capsid proteins of some RNA viruses can translocate to the nucleus and interfere with cellular
phenotypes. In this study we found that the VP1 capsid protein of coxsackievirus B3 (CVB3) was
dominantly localized in the nucleus of the cells transfected with VP1-expressing plasmid. The VP1
nuclear localization also occurred in the cells infected with CVB3. Truncation analysis indicated that the
VP1 nuclear localization sequence located near the C-terminal. The substitution of His220 with
threonine completely abolished its translocation. The VP1 proteins of other CVB types might have
the nuclear localization potential because this region was highly conserved. Moreover, the VP1 nuclear
localization induced cell cycle deregulation, including a prolonged S phase and shortened G2-M phase.
Besides these ﬁndings, we also found a domain between Ala72 and Phe106 that caused the VP1
truncates dotted distributed in the cytoplasm. Our results suggest a new pathogenic mechanism of CVB.
& 2012 Elsevier Inc. All rights reserved.The nucleus in a cell sequesters the genomic material from the
cytoplasm and keeps it in a homeostatic environment. The nucleus
is comparted from the cytoplasm by nuclear envelope, in which
there are numerous pores that allow small molecules, such as ions,
metabolites, and globular protein smaller than 40 kDa, freely pas-
sing through (McLane and Corbett, 2009; Wu et al., 2011). Protein
over 40 kDa cannot pass through the nuclear pores unless it owns
nuclear localization signal (NLS) sequence. NLS usually is rich in
basic amino acids and resides near the C-terminal of the protein
(McLane and Corbett, 2009). Through binding to nuclear import
receptors including importin a and b, the NLS guides the protein
transportation into the nucleus (Goldfarb et al., 2004).
The biosynthesis of RNA viruses occurs in the cytoplasm. The
capsid proteins of RNA viruses are also distributed in the
cytoplasm to assemble the progeny virions (Wychowski et al.,
1985). However, recent studies reveal that the capsid proteins of
some RNA viruses, such as Dengue virus (Colpitts et al., 2011),
West Nile virus (WNV) (Bhuvanakantham et al., 2010; Yang et al.,
2008), and porcine reproductive and respiratory syndrome virus
(PRRSV) (Pei et al., 2008), can translocate to the nucleus and,
thereafter, disturb the nuclear functions. In the cells infected with
Dengue virus, a large portion of the Dengue virus capsid proteinll rights reserved.
ao), zhonghmu@gmail.com,localizes in the nucleus and acts as a histone mimic to disrupt
nucleosome formation (Colpitts et al., 2011). The capsid protein C
of WNV localizes in the nucleus through importin-mediated
pathway and can be phosphorylated by protein kinase C (PKC).
The phosphorylation of the WNV capsid protein C inﬂuences its
nuclear trafﬁcking by modulating the efﬁciency of protein
C-importin-a binding (Bhuvanakantham et al., 2010) and subse-
quently induces p53-dependent apoptosis (Yang et al., 2008). The
nucleocapsid protein N is the most abundant structural protein of
PRRSV. During PRRSV infection, the N protein is speciﬁcally
localized in the nucleus and nucleolus in addition to its normal
cytoplasmic distribution (Pei et al., 2008). In vivo infection with
the NLS-null PRRSV mutant causes reduced viremia and increased
production of neutralizing antibodies in the infected pigs. There-
fore, it is evident that the nuclear localization of protein N plays a
critical role in the PRRSV pathogenesis and host responses to
PRRSV (Pei et al., 2008).
Coxsakieviruses are members of Picornaviridae family. Group B
coxsackieviruses (CVB), which include six types (CVB1–CVB6), are
the major pathogens of human myocarditis and dilated cardio-
myopathy (Fairweather et al., 2012; Yajima and Knowlton, 2009).
CVB genome is a single-stranded RNA of 7.4 kb with positive
polarity (Lindberg et al., 1987). With only one open reading frame,
CVB genome encodes a large polyprotein, which is cleaved into
the mature viral proteins by viral proteinases 2A and 3C (Lindberg
et al., 1987; Sean and Semler, 2008). CVB capsid is composed of
four structural proteins, VP1, VP2, VP3, and VP4. The VP1 protein,
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ing antigen of the virus (Muckelbauer and Rossmann, 1997).
Previous studies showed that the VP1 protein not only is a
structural unit of the capsid, but also involves in the viral
pathogenesis. A single amino acid mutation in the VP1 protein
can signiﬁcantly change the plaque phenotype of CVB3 (Zhang
et al., 1995). Mutations in the 50 untranslated region and VP1-
coding sequence can attenuate the cardiovirulence of CVB
(Cameron-Wilson et al., 1998; Tam et al., 2003). Single amino
acid change (Q164K) within the exposed region of the VP1 protein
can change the cytolytic and apoptotic abilities of CVB2 (Gullberg
et al., 2010). These ﬁndings indicate that the VP1 protein plays a
critical role in the pathogenesis of CVB.
There is no report about the CVB VP1 protein translocation
from the cytoplasm to the nucleus so far. In the present study, we
found that the VP1 protein of CVB3 could speciﬁcally localize in
the nucleus through a NLS sequence that located near its
C-terminal, and the nuclear localization of CVB3 VP1 protein
could deregulate the cell cycle of the VP1-expressing cells.Results
Fusion protein EGFP-CVB3 VP1 predominantly localizes in the nucleus
HeLa cells were transfected with plasmids expressing enhanced
green ﬂuorescence protein (EGFP)-tagged CVB3 proteins VP1,Fig. 1. The nuclear localization of EGFP-CVB3 VP1 protein in HeLa cells. HeLa cells were
and the EGFP-VP1 protein of EV71, respectively. The localization of these EGFP-tagged p
of CVB3. (D) is the enlargement of the framed part in (C). (E)–(H). The localization of
localization of the EGFP-VP1 of EV71. (L) is the enlargement of the framed part in (K).
enlargement of the framed part in (O).VP4–VP2, 2A, 2B, 2C, 3A, 3B, 3C, and 3D, respectively. The expres-
sion of EGFP was observed at 6, 12, 24, 48, and 72 h post-
transfection. Except plasmid pEGFP-2A, the others generated bright
green ﬂuorescence in the transfected cells. Surprisingly, we found
that the EGFP-CVB3 VP1 (hereafter, EGFP-VP1) protein was mainly
located in the nucleus, while the others were distributed in the
entire cells or only in the cytoplasm (Fig. 1). As a comparison, a
plasmid expressing the EGFP-tagged VP1 protein of enterovirus 71
(EV71) was also applied to transfect HeLa cells. The EGFP-EV71 VP1
was distributed evenly in the cells (Fig. 1).
HeLa is a cervical cancer-originated cell line. To verify this
observation, Vero cells were transfected with pEGFP-VP1. A
similar result was obtained in the transfected Vero cells, in which
the EGFP-VP1 protein was concentrated in the nucleus (Fig. S1,
Supplementary data).
The intact CVB3 VP1 protein is also mainly localized in the nucleus
The molecular weight of CVB3 VP1 protein is about 34 kDa.
Theoretically, it can passively diffuse into the nucleus (Tran and
Wente, 2006). To check the distribution of the intact CVB3 VP1
protein, HeLa cells were transfected with pcDNA3.1-VP1, the
plasmid expressing untagged CVB3 VP1. The localization of
CVB3 VP1 was detected by a monoclonal antibody against
enteroviral VP1. Interestingly, rather than distributing evenly in
the entire cell, the untagged CVB3 VP1 was exclusively localized
in the nucleus (Fig. 2B). The localization of untagged CVB3 VP1transfected with plasmids expressing the EGFP-VP1 and EGFP-3C proteins of CVB3
roteins was observed at 12 h post-transfection. (A)–(D) The localization of EGFP-3C
EGFP-VP1 of CVB3. (H) is the enlargement of the framed part in (G). (I)–(L) The
(M)–(P) The EGFP-C1 expression in the pEGFP-C1-transfected HeLa cells. (P) is the
Fig. 2. The nuclear localization of CVB3 VP1 protein in HeLa cells. HeLa cells were transfected with pEGFP-VP1 (A) and pcDNA3.1-VP1 (B), respectively or infected with
CVB3 (MOI¼1) (C). The cells transfected with the plasmids were ﬁxed at 12 h post-transfection and detected with mouse monoclonal anti-enteroviral VP1 (clone 5-D8/1)
antibody (Dako) and TRITC-labeled anti-mouse IgG antibody. One hour before the immunoﬂuorescence detection, DAPI was added to the culture medium.
The cytoplasmic and nuclear proteins in the cells infected with CVB3 viruses were extracted separately at 10 h p.i., and applied to Western blotting detection for the
CVB3 VP1 protein. Histone H3 and b-actin were employed as the loading controls of nuclear and cytoplasmic proteins, respectively. (A) The localization of EGFP-VP1
protein in the HeLa cells transfected with pEGFP-VP1. (B) The localization of CVB3 VP1 protein in the HeLa cells transfected with pcDNA3.1-VP1. (C) The cytoplasmic and
nuclear VP1 proteins in the CVB3-infected HeLa cells detected by Western blotting. The CVB3-infected samples collected from two parallel wells were loaded as repeats.
NC: normal control.
Fig. 3. Mapping the NLS-coding sequence of CVB3 VP1. (A) The strategy of constructing the truncated VP1-expressing plasmids. The green box represents the EGFP-coding
sequence. The brown box represents the VP1 truncate that localized in the nucleus. The numbers marked in the boxes represent the nucleotide locations. The digitals after
VP1D represent the deleted sequence. (B) The representative images of the EGFP-tagged VP1 truncates in HeLa cells. HeLa cells were transfected with the VP1 truncate-
expressing plasmids. The localization of the EGFP-tagged VP1 truncates were observed at 24 h post-transfection. DAPI was added to the culture medium to stain the nuclei
1 h before the observation. The cells with the nuclear localized truncates were marked by the white arrowheads. The red arrowheads show the cells with dotted
distributed truncates. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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assay (Fig. 2A). This observation implied that the nuclear localiza-
tion of CVB3 VP1 was not a consequence of passive diffusion but
active translocation.
To identify the VP1 localization in the CVB3-infected cells, the
VP1 protein expressed in the HeLa cells infected with 1 multi-
plicity of infection (MOI) of CVB3 viruses was detected. Western
blotting showed that the VP1 protein could be detected in the
cytoplasm and nucleus at 10 h post-infection (p.i.) in two
parallel CVB3-infected samples (Fig. 2C). These detections veriﬁed
that the CVB3 VP1 protein could localize in the nuclei of the
infected cells.Fig. 4. The localizations of the CVB3 VP1 proteins with mutations in the NLS sequence
CVB3 (H3 strain, Genbank accession: U57056)) and EV71 (FY0805 isolate, Genbank acc
CVB3 VP1 were replaced by acidic amino acids in EV71 VP1. (B) The mutations in VP1
proteins in the HeLa cells transfected with pcDNA3.1-VP1, pcDNA3.1-VP1H220T, and
enteroviral VP1 (clone 5-D8/1) antibody and TRITC-labeled anti-mouse IgG antibody a
(D) The localizations of EGFP-VP1 and EGFP-VP1H220T proteins in the HeLa cells transfec
a confocal microscope LSM 700 (Carl Zeiss) at 24 h post-transfection. (For interpretatio
version of this article.)The nuclear localization sequence of CVB3 VP1 resides between the
Met213 and Ile275 near its C-terminal
To locate the NLS sequence of CVB3 VP1, two truncated CVB3
VP1-coding sequences with intervals of about 300 nt were
generated and expressed by pEGFP-C1 (Fig. 3A). In HeLa cells,
the EGFP-tagged VP1 truncates, EGFP-VP1D322–843 and EGFP-
VP1D547–843, could not localize in the nucleus (Fig. 3B). There-
fore, the NLS sequence was preliminarily located in the C-
terminal of CVB3 VP1 protein.
Four C-terminal truncates of CVB3 VP1 were further generated
and expressed in HeLa cells (Fig. 3A). The truncate EGFP-VP1D1–546,. (A) The alignment of the VP1 protein sequences between Met213 and Ile275 of
ession: HQ882182). Two basic amino acids, His220 and Lys230 (marked in red), in
H220T and VP1K230P. (C) The localizations of wild-type VP1, VP1H220T, and VP1K230P
pcDNA3.1-VP1K230P. The cells were ﬁxed and detected with monoclonal anti-
t 24 h post-transfection. DAPI was added to the medium 1 h before the ﬁxation.
ted with pEGFP-VP1 and pEGFP-VP1H220T. The transfected cells were observed with
n of the references to color in this ﬁgure legend, the reader is referred to the web
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localized (Fig. 3B). Thus, the location of the NLS sequence was
narrowed between Met213 and Ile275 (nt637–nt825). Since the
truncate EGFP-VP1D1–702 did not localize in the nucleus (Fig. 3B),
we concluded that the amino acids adjacent to Arg234–Ile235
(nt699–nt705) were necessary for the nuclear localization of
CVB3 VP1.
Because the localization of CVB3 VP1 differed from that of
EV71 VP1 in the transfected cells, the sequences between Met213
and Ile275 in the VP1 proteins of CVB3 and EV71 were compared
(Fig. 4A). The alignment showed that two basic amino acids in
CVB3 VP1 protein, the 220th histidine (H) and the 230th lysine
(K), were substituted by acidic threonine (T) and proline (P),
respectively, in EV71 VP1. The amino acid difference in these
particular sites might determine the distinct localizations of the
VP1 proteins of CVB3 and EV71. Therefore, we performed site-
directed mutagenesis to generate two CVB3 VP1 mutants, the
VP1H220T and VP1K230P, by substituting the His220 and Lys230
with threonine and proline, respectively, in both EGFP-tagged and
untagged CVB3 VP1 proteins (Fig. 4B). In HeLa cells, the VP1K230P
protein with K230P mutation still localized in the nucleus, while
both the untagged and EGFP-tagged VP1H220T proteins with
H220T mutations did not localized in the nucleus. Instead, dotted
distribution of VP1H220T was found in the cytoplasm (Fig. 4C and D).
These data indicate that the His220 was a key amino acid residue in
the NLS of CVB3 VP1 protein.
The region between Ala72 and Phe106 of CVB3 VP1 protein
determines its dotted distribution in the cytoplasm
Above observations showed that the VP1H220T protein was
distributed in a dotted pattern in the cytoplasm. To clarifyFig. 5. Mapping the dotted distribution domain of CVB3 VP1 protein. (A) Construction
The brown box is the full-length VP1-coding sequence. The yellow boxes coded the
truncated proteins that distributed evenly in the cells. (B) The representative images of
with the truncate-expressing plasmids and observed at 24 h post-transfection. The a
interpretation of the references to color in this ﬁgure legend, the reader is referred towhether the dotted distribution was related to the VP1 NLS
sequence, serial VP1 truncations with intervals of about 50 amino
acids (150 nt) were generated and expressed with EGFP tag
(Fig. 5A). In the HeLa cells expressing these truncates, the
truncate VP1D703–843, VP1D547–843, VP1D445–843, and
VP1D322–843 were distributed in dotted pattern, while the
truncate VP1D214–843 and VP1D118–843 were evenly distrib-
uted in the cytoplasm (Fig. 5B). These data indicate that there was
a domain located in the region between the 72nd alanine to the
106th phenylalanine that determined the dotted distribution of
the NLS-null CVB3 VP1 proteins.
CVB3 VP1 nuclear localization induces cell cycle deregulation
To evaluate the impact of CVB3 VP1 nuclear localization on the
cells, HeLa cells were transfected with pEGFP-VP1 and pEGFP-
VP1H220T, and the cell cycle, NF-kB expression, and apoptosis in the
treated cells were detected by ﬂow cytometry and Western
blotting. We did not observed a signiﬁcant alteration in the
expression of NF-kB p65 and cleaved poly(ADP-ribose) polymerase
1 (PARP1) (data not shown). However, the cell cycle in the EGFP-
VP1-expressing cells without synchronization treatment was
altered signiﬁcantly from that of the EGFP-VP1H220T-expressing
cells at the time point of 48 h post-transfection. Compared to the
cell cycle in the normal control group (25.571.3% for S phase and
8.072.4% for G2-M phase) at 48 h post-transfection, the EGFP-
VP1-expressing cells showed prolonged S phase (44.270.5%) and
shortened G2-M phases (2.573.6%), while the EGFP-VP1H220T-
expressing cells showed prolonged S phase in less extent
(34.174.2%) and relatively normal G2-M phases (6.572.2%)
(Fig. 6). There was no signiﬁcant change among the cell cycles of
three groups at 24 h post-transfection, possibly due to the plasmidsof the CVB3 VP1 truncates. The green boxes represent the EGFP-coding sequences.
truncated proteins that were not nuclear localized. The white boxes coded the
the EGFP-tagged VP1 truncates expressed in HeLa cells. The cells were transfected
rrowheads show the cells with the dotted distributed EGFP-VP1 truncates. (For
the web version of this article.)
Fig. 6. The cell cycle of the HeLa cells expressing CVB3 VP1 proteins. HeLa cells were transfected with pEGFP-VP1 and pEGFP-VP1H220T, respectively. The cells were
harvested at 24 and 48 h post-transfection and dyed with PI reagents. About 20,000 cells were counted for cell cycle by a ﬂow cytometer FACSCalibur (mean7standard
deviation, n¼3). NC: normal control.
T. Wang et al. / Virology 433 (2012) 513–521518needed time for gene expression. A similar prolonged S phase was
also observed in the synchronized EGFP-VP1-expressing cells at
48 h post-transfection (Fig. S4, Supplementary data). These data
suggest that the event of CVB3 VP1 nuclear localization alone could
sufﬁciently deregulate the cell cycle.Discussion
The capsid protein of picornavirus, which functions as the
structural unit of the viral particle, is usually localized in the
cytoplasm (Wychowski et al., 1985). Recent studies demonstrated
that the capsid proteins of some RNA viruses, e.g., Dengue virus
(Colpitts et al., 2011), West Nile virus (Bhuvanakantham et al.,
2010; Yang et al., 2008), coronavirus (Surjit et al., 2006), and
PRRSV (Pei et al., 2008), can localize in the nucleus, and thereafter,
interfere with the host cellular phenotypes including the disrup-
tion of nucleosome formation (Colpitts et al., 2011), cell cycle
(Cawood et al., 2007), and apoptosis (Yang et al., 2008). These
studies suggest that, except determining the viral tropism, the
capsid proteins can directly interact with the nucleus and play
roles in the pathogenesis of diseases caused by these viruses.
So far, there is no report about the nuclear localization of
coxsackievirus capsid protein. In this study, we found that CVB3
VP1 protein, mediated by a NLS sequence near its C-terminal, was
actively localized in the nucleus. Moreover, the cell cycle was
disrupted in the VP1-expressing cells. Our ﬁndings suggest that
there may be a direct interaction between the VP1 capsid protein
of CVB3 and the cellular nuclear proteins, and this interaction
may contribute to the pathogenesis of CVB3.
Our data demonstrate that both the EGFP-tagged and untagged
VP1 proteins were predominantly localized in the nuclei of the
HeLa cells (Figs. 1 and 2). The EGFP-VP1 expression in Vero cells
veriﬁed the observation in HeLa cells (Fig. S1). The VP1 protein
nuclear localization was further conﬁrmed by Western blotting in
the cells infected with CVB3 viruses (Fig. 2). These results indicate
that the VP1 nuclear localization is an intrinsic procedure in the
life cycle of CVB3.
CVB3 VP1 protein is approximately 34 kDa in molecular
weight. Theoretically it can freely pass through the nuclear pore
as long as it is globular. However, the EGFP-VP1 protein is about
60 kDa, that is beyond the 40 kDa limit of passive diffusion
through the nuclear pores for a globular protein. On the other
hand, previous study showed that the conformation of CVB3 VP1
was not globular when it assembled the capsid with VP2, VP3,and VP4 (Muckelbauer et al., 1995a; Muckelbauer et al., 1995b).
Therefore, we speculated that CVB3 VP1 protein might own a NLS
sequence that helped the EGFP-VP1 protein passing through the
nuclear pore. To locate the NLS sequence in the CVB3 VP1 protein,
truncation strategy was employed in this study. By expressing
two VP1 truncates at about 100-amino acid intervals, the NLS
sequence was roughly located near the C-terminal of VP1 protein.
Further truncations narrowed the NLS sequence in the region
between Met213 and Ile275 (Fig. 3).
Although the picornaviral genomes share great similarity in
terms of structure and sequence (Tracy et al., 2006), the localiza-
tion of EV71 VP1 protein was apparently different from that of
CVB3 VP1 protein in HeLa cells (Fig. 1). The localization difference
between the VP1 proteins of CVB3 and EV71 provided a shortcut
for predicting the NLS sequence of CVB3 VP1. NLS is usually a
basic amino acid-rich sequence (McLane and Corbett, 2009; Tran
and Wente, 2006). The alignment for the Met213–Ile275
sequences showed that two basic amino acids (His220 and
Lys230) in CVB3 VP1 were substituted by acidic amino acid
threonine and proline, respectively, in EV71 VP1 (Fig. 4A). By
expressing the mutants VP1H220T and VP1K230P in HeLa cells, we
found that the VP1H220T mutant completely abolished the nuclear
translocation (Fig. 4). The result indicates that the His220 is one of
the determinative amino acids in the NLS of CVB3 VP1 protein.
By comparing the sequence around His220 with the reported
NLS sequences (McLane and Corbett, 2009), no typical NLS
sequence was identiﬁed in CVB3 VP1 protein. Furthermore, the
VP1D1–702 and VP1D703–843 truncates were not nuclear loca-
lized (Figs. 3 and 5). These observations suggest that the NLS
sequence of CVB3 VP1 protein might span a wide region (Fig. 7).
Alignment of the Met213–Ile275 sequences in the VP1 proteins of
CVB1 to CVB6 showed that this region was highly conserved
(Fig. 7). It is possible that the VP1 proteins of all CVB types may
also have the potential of nuclear localization.
Another interesting ﬁnding in this study is that the full-length
mutant VP1H220T and some wild-type VP1 truncates distributed in
a dotted pattern rather than evenly distributed in the cytoplasm.
Using truncation strategy, we found that the dotted distribution
was dependent on a domain located between Ala72 and Phe106
(Figs. 5 and 7). It seems that this is a membrane-binding domain
that keeps the truncated VP1 proteins binding to the cytoplasmic
membrane structures. Further study is needed to elucidate this
molecular event.
We noticed that there was abundant cytoplasmic VP1 protein in
the cells infected with CVB3 (Fig. 2C). A part of the cytoplasmic VP1
Fig. 7. Diagram of the NLS sequence of CVB3 VP1. (A) The Locations of the NLS sequence in CVB3 VP1. Dark box: the region where the NLS sequence was located. Grey box:
this part caused the dotted distribution of CVB3 VP1. ‘‘aa’’ stands for amino acid. (B) The alignment of the VP1 sequences between Met213 and ILe275 of the six CVB types.
The His220 and Lys230 are marked with the dark and white arrowheads, respectively. The grey arrowhead shows the bound of VP1D1–702 and VP1D702–843.
T. Wang et al. / Virology 433 (2012) 513–521 519should be that assembled in the progeny virus capsid. It might also be
a result of the relocation of nuclear localized VP1 somehow caused by
CVB3 infection. Previous studies demonstrated that enteroviral pro-
tease 2A could cause the cytoplasmic redistribution of nuclear
proteins through cleaving the nuclear pore complex (NPC) compo-
nents (Gustin and Sarnow, 2001; Gustin, 2003). Indeed, considerable
amount of cytoplasmic EGFP-VP1 could also be observed in the
pEGFP-VP1-transfected cells with CVB3 infection simultaneously (Fig.
S3, Supplementary data).
The nuclear trafﬁcking of viral capsid proteins can disrupt the
host cellular phenotypes (Bhuvanakantham et al., 2010; Cawood
et al., 2007; Colpitts et al., 2011; McLane and Corbett, 2009; Yang
et al., 2008). The host chromatin and histone proteins are always
the targets of the viral capsid proteins (Bhuvanakantham et al.,
2010; Colpitts et al., 2011; Surjit et al., 2006; Yang et al., 2008;
Zhirnov and Klenk, 1997). Dengue virus capsid protein can act as a
histone mimic to disrupt the nucleosome formation (Colpitts et al.,
2011). WNV capsid protein C can bind to human double minute 2
(HDM2) and induce p53-dependent apoptosis (Bhuvanakantham
et al., 2010). Inﬂuenza virus matrix protein M1 can interact with
the core histones (Zhirnov and Klenk, 1997). The nucleocapsid
protein N of severe acute respiratory syndrome coronavirus arrest
the cells in S phase by directly inhibiting the cyclin-CDK complex
(Surjit et al., 2006). To evaluate whether the CVB3 VP1 nuclear
localization affects cellular phenotype, the cell cycle of the HeLa
cells expressing CVB3 VP1 and VP1H220T proteins was prelimina-
rily analyzed. Our results demonstrate that the VP1 nuclear
localization caused a prolonged S phase and shortened G2-M
phase in the asynchronous cells (Fig. 6) and a prolonged S phase
only in the synchronized cells (Fig. S4, Supplementary data). These
data imply that the VP1 nuclear localization may somehow
interfere with cellular genome replication or disrupt cell cycle
regulators, e.g., cyclin A, CDK2, and retinoblastoma protein (Eguchi
et al., 2007). The precise mechanism needs further study.
Previous studies (Feuer et al., 2002, 2004; Feuer and Whitton,
2008) showed that CVB3 replication is inﬂuenced by host cell
cycle status. The protein synthesis and viral production of CVB3
are dramatically higher in HeLa cells arrested at the G1 or G1/S
stage, while the virus-infected cells at the G0 or G2-M stage
express less protein and make less infectious CVB3. In addition,
CVB3 infection can also disrupt host cell homeostasis by inducing
cell cycle arrest through increasing ubiquitin-dependent proteo-
lysis of cyclin D1 (Luo et al., 2003). Therefore, the shortened G2-M
phase induced by the VP1 nuclear localization may facilitate the
biosynthesis of CVB3.
However, it should be emphasized that this was only a
preliminary survey of the biological impact of the CVB3 VP1
nuclear localization. The overexpression strategy may notproperly represent the natural scenario of CVB3 infection in cells.
Therefore, more extensive studies are needed to well interpret
this molecular event in CVB3 infection.
Taken together, CVB3 VP1 protein owns nuclear localization
sequence near its C-terminal and can actively translocate from
the cytoplasm into the nucleus. The nuclear localization of CVB3
VP1 protein can disrupt the cell cycle, and may be one of the
pathogenic mechanisms of CVB3.Materials and methods
Cell lines and viruses
HeLa and Vero cells were cultured in Dulbecco Modiﬁed Eagle
Medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with
10% fetal bovine serum (FBS) (Biological Industries, Kibbutz Beit
Haemek, Israel) and antibiotics (50 U/ml penicillin and 0.1 mg/ml
streptomycin) at 37 1C with 5% CO2. CVB3 H3 strain was passaged
in HeLa cells and titered by plaque assay as described previously
(Wang et al., 2012; Zhong et al., 2008).
Plasmid constructions
A pcDNA3.1-based, EGFP-expressing plasmid, designated as
pEGFP-C1 (Wang et al., 2012), was used for expressing the full-
length and truncated CVB3 VP1 proteins. The coding sequence of
CVB3 VP1 was obtained by polymerase chain reaction (PCR) from
pMKS1, a plasmid carries the full-length cDNA of CVB3 H3
genome (Feuer et al., 2002). Plasmid pEGFP-VP1 was constructed
by inserting the CVB3 VP1-coding sequence, which contained 843
nucleotides (nt) and coded 281 amino acids (aa), to the Hind
III-Xba I site at the 30 end of the EGFP-coding sequence in pEGFP-
C1. A series of truncated CVB3 VP1 sequences were generated
from the pEGFP-VP1 by PCR assay (Figs. 3 and 5). The PCR
products were puriﬁed by 1% agarose gel electrophoresis and
the Gel Extraction Kit WD412 (Huashun Biotech, Shanghai,
China). The puriﬁed PCR products were digested with Hind III
and Xba I (TaKaRa, Dalian, China), and ligated to the pEGFP-C1
that has been digested with the same restriction enzymes. All
plasmids were conﬁrmed by sequencing (Invitrogen Beijing,
Beijing, China). The primers used in these constructions were
listed in Table 1 (Supplementary data).
Site-directed mutagenesis
The amino acid alignment for the Met213–Ile275 peptides in
the VP1 proteins of CVB3 (Genbank accession: U57056) and EV71
T. Wang et al. / Virology 433 (2012) 513–521520(Genbank accession: HQ882182) showed that two basic amino
acids, His220 and Lys230, in the CVB3 VP1 were replaced by
acidic amino acids, threonine (T) and proline (P), in the EV71 VP1,
respectively. Therefore, two mutants of CVB3 VP1, VP1H220T and
VP1K230P, were generated in this study by overlapping PCR
strategy as described previously (Wang et al., 2012). Brieﬂy, for
generating VP1H220T, the pEGFP-VP1 DNA was ampliﬁed with VP1
sense primer and H220T antisense primer, and with H220T sense
primer and VP1 antisense primer (Table 1, Supplementary data),
respectively. The PCR productions mixed and ampliﬁed with VP1
sense and antisense primers together. The resultant DNA was
digested with Hind III and Xba I and cloned into pEGFP-C1.
VP1K230P was generated as the same protocol except using the
K230P primers (Table 1, Supplementary data).Transfection and ﬂuorescence observation
Approximately 70% conﬂuent HeLa cells were transfected with
various plasmids by Lipofectamine 2000 (Invitrogen, Carlsbad,
CA) as described previously (Tong et al., 2011). The EGFP expres-
sion in the transfected cells with various plasmids were observed
with a microscope Axiovert 200 (Carl Zeiss, Gottingen, Germany)
or a confocal microscope LSM 700 (Carl Zeiss MicroImaging, Jana,
Germany). DAPI was added to the culture 1 h before the micro-
scopy examination for staining the nuclei.Immunoﬂuorescence assay
HeLa cells grown in a 24-well plate were washed with
precooling phosphate buffered saline (PBS) for 2 times and ﬁxed
with freshly prepared 4% formaldehyde for 15 min. The ﬁxed cells
were permeabilized with 0.1% Triton X-100 in PBS for 10 min
and blocked with 1% bovine serum albumin (BSA) for 20 min.
The blocked cells were incubated with 1:500 diluted monoclonal
mouse anti-enteroviral VP1 (clone 5-D8/1) antibody (Dako,
Glostrup, Denmark) at 4 1C overnight. After washing in PBS for
5 min3 times, the cells were incubated with 1:1000 diluted
TRITC-labeled goat anti-mouse IgG antibody (Zhongshan Jinqiao
Biotech, Beijing, China). The cells were dyed with 0.1 mg/ml DAPI
and observed with Axiovert 200.Western blot
The cytoplasmic and nuclear proteins of the CVB3-infected
HeLa cells were separately extracted 10 h p.i. with the Protein
Extraction Kit P0028 (Beyotime Biotech, Beijing, China), and
quantitated with Bradford reagents (Bio-Rad, Hercules, CA). The
protein extracts (2 mg/lane) were separated by 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
The separated proteins were transferred to a polyvinylidene
ﬂuoride (PVDF) membrane (0.22 mm, Millipore, Billerica, MA).
The membrane was blocked with 5% nonfat milk for 2 h at
37 1C, and overnight incubated at 4 1C with antibodies against
enterovirus VP1 (Dako), histone H3 (Abcam, Cambridge, MA), and
b-actin (Santa Cruz Biotechnology, Santa Cruz, CA), respectively.
The membrane was routinely washed and then incubated with a
horseradish peroxidase-conjugated anti-IgG antibody (Zhongshan
Goldenbridge Biotech) at a dilution of 1:4000 for 2 h at 37 1C. The
membrane was stained with the SuperSignal kit (Pierce, Rockford,
IL) and imaged by a charge-coupled camera LAS4000 (Fujiﬁlm,
Tokyo, Japan). Histone H3 and b-actin were employed as loading
controls for the nuclear and cytoplasmic proteins, respectively.Flow cytometry
The transfected HeLa cells were collected by 0.5% trypsin
digestion at 24 and 48 h post-transfection, respectively. The cells
were washed with PBS 2 times, and ﬁxed with 75% precooling
ethanol. Approximately 1106 cells were washed and resus-
pended in 0.4 ml of precooling PBS two times. The cells were
incubated with 40 mg/ml of propidium iodide (PI) (Sigma, St.
Louis, MO) and 40 mg/ml of RNase (Sigma) at 37 1C for 30 min,
and applied to cell cycle analysis with a ﬂow cytometer FACSCa-
libur (BD Bioscience, San Jose, CA). The data were analyzed by
Cell-Quest ModiFit software (BD Bioscience) and plotted by
Sigmaplot 11 (Systat Software, Richmond, CA).Acknowledgments
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